# Glen Tullman

> Glen Tullman is a serial health-tech entrepreneur and CEO of Transcarent, the consumer-directed health and care platform he founded in 2021. Over three decades he turned Allscripts into the dominant electronic health records provider, founded Livongo Health and sold it to Teladoc for $18.5 billion - the largest consumer digital health deal in history - and co-founded 7wireVentures, one of the top-returning venture funds in Illinois. Now leading Transcarent's $621M acquisition of Accolade and pushing AI-powered 'WayFinding' tools into employee benefits, Tullman is also a Giving Pledge signatory who has committed most of his estimated $1 billion fortune to healthcare and education.

- **Role:** Chief Executive Officer at Transcarent
- **Organizations:** Transcarent, 7wireVentures, 62 Ventures, Tullman Family Office, Breakthrough T1D (JDRF) - Illinois Life Director
- **From:** Highland Park, Illinois, United States
- **Nationality:** American
- **Education:** High School Diploma, New Providence High School, BA, Economics and Psychology, Bucknell University, Postgraduate study, Social Anthropology, University of Oxford (St Antony's College)
- **Known for:** Led Livongo Health's $18.5 billion merger with Teladoc - largest consumer digital health deal in history, Led Livongo through the largest consumer digital health IPO in history (2019), CEO of Allscripts for 15 years, building it into a leading EHR provider

## Career timeline

- **1981** — Graduated from Bucknell University with degrees in economics and psychology
- **1981-1982** — Studied social anthropology at Oxford University
- **1982-1992** — Joined Certified Collateral Corporation (CCC Information), rose to President and COO, grew revenue from $30M to $100M
- **1992-1997** — CEO of Enterprise Systems, the leading hospital resource management company; took it public and sold to McKesson/HBOC
- **1997-2012** — CEO of Allscripts for 15 years; led electronic health records revolution and multiple public offerings
- **2012** — Co-founded 7wireVentures, an early-stage digital health venture capital firm (now $500M+ AUM)
- **2014** — Founded Livongo Health after son Sam's Type 1 diabetes diagnosis, to empower people with chronic conditions
- **2019** — Led Livongo through the largest consumer digital health IPO in history; received RFK Human Rights Ripple of Hope Award
- **2020** — Orchestrated Livongo's $18.5 billion merger with Teladoc Health, the largest digital health deal in history
- **2021** — Founded and became CEO of Transcarent; named Forbes Top 10 Healthcare Leader of the Decade
- **2024** — Launched 62 Ventures, a $100M fund; Transcarent raised $126M Series D led by General Catalyst
- **2024** — Signed The Giving Pledge, committing the majority of an estimated $1B fortune to philanthropy
- **2025** — Transcarent completed $621M acquisition of Accolade; named to CNBC Disruptor 50

## Achievements

- Led Livongo Health's $18.5 billion merger with Teladoc - largest consumer digital health deal in history
- Led Livongo through the largest consumer digital health IPO in history (2019)
- CEO of Allscripts for 15 years, building it into a leading EHR provider
- Founded 7wireVentures, one of the highest-returning VC funds in Illinois ($500M+ AUM)
- Forbes Top 10 Healthcare Leaders of the Decade (2021)
- Robert F. Kennedy Human Rights Ripple of Hope Award (2019)
- Took Enterprise Systems public and sold to McKesson/HBOC
- Founded 62 Ventures ($100M fund) in 2024
- Signed the Giving Pledge, committing majority of ~$1B fortune to philanthropy
- Committed $100M specifically to diabetes research
- Transcarent named to 2025 CNBC Disruptor 50
- Transcarent completed $621M acquisition of Accolade (2025)
- Author of 'On Our Terms: Empowering the New Health Consumer'
- Co-founder of SoCore Energy (solar), acquired by Edison International
- Founded Modern Teacher (classroom technology), now part of LEAP Innovations

## Latest updates

- **2025-06** — Transcarent named to 2025 CNBC Disruptor 50 list, recognized for AI and generative AI in healthcare
- **2025-04** — Transcarent completed $621M acquisition of Accolade; Glen Tullman continues as CEO of combined organization
- **2025-05** — Glen Tullman signed The Giving Pledge, publicly committing majority of ~$1B fortune to philanthropy
- **2025-02** — MedCity News covered Tullman's navigation of the healthcare system he aimed to disrupt
- **2024-12** — Declared 2025 'the year of AI implementation' in healthcare; highlighted WayFinding as agentive AI product
- **2024-05** — Transcarent raised $126M Series D led by General Catalyst; Tullman announced Accolade acquisition intent
- **2024-04** — Launched 62 Ventures, a new $100M fund focused on health, education, and sustainability

## Links

- Website: https://transcarent.com
- LinkedIn: https://www.linkedin.com/in/glen-tullman-76108566/
- Twitter/X: https://twitter.com/GlenTullman
- Facebook: https://facebook.com/transcarent

---

Profile page: https://yespress.io/glen-tullman
Published by YesPress — https://yespress.io
Last updated: 2026-05-26